Rhinomed Ltd
ASX:RNO
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| AU |
|
Rhinomed Ltd
ASX:RNO
|
11.4m AUD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
997.2B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.6B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
281.1B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.5B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
230.9B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.1B GBP |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.7B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD |
Loading...
|
Market Distribution
| Min | -16 177 900% |
| 30th Percentile | -544.7% |
| Median | -27.7% |
| 70th Percentile | 3.1% |
| Max | 3 174 540% |
Other Profitability Ratios
Rhinomed Ltd
Glance View
Rhinomed Ltd. is medical technology company, which engages in the identification, acquisition, and commercialization of stage therapeutic delivery technologies. The company is headquartered in Richmond, Victoria. The company went IPO on 2007-09-21. The Company’s products include Mute, Turbine, Pronto Sleep, and Pronto Clear. The Mute is a nasal technology that is designed to allow the user to manage the sleep by breathing more and snoring less. The Turbine is a nasal dilator designed to assist the user to breathe during aerobic exercise. Pronto Sleep, which combines the benefits of a nasal dilator, to open the nose and improve airflow, with the soothing vapors of four pure essential oils. Pronto Clear, which combines the benefits of a nasal dilator, to open the nose and improve airflow, with the ability to deliver the vapors of six pure essential oils traditionally known to clear a stuffy nose naturally. Its products, including Turbine and Mute, are sold online and through pharmacies, sleep clinics, and sports stores.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Rhinomed Ltd is -146%, which is in line with its 3-year median of -146%.
Over the last 3 years, Rhinomed Ltd’s Net Margin has increased from -203% to -146%. During this period, it reached a low of -221.8% on Jun 30, 2021 and a high of -58% on Jun 30, 2022.
